Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: What is next after the FDA black box warning

Journal of Pediatric and Adolescent Gynecology

Volumn 18, Issue 3, 2005, Pages 183-

  Omar, Hatim ^a   Kives, Sari ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADOLESCENT PREGNANCY; BONE DENSITY; CONTRACEPTION; COST BENEFIT ANALYSIS; DOMESTIC VIOLENCE; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; POVERTY; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; BONE DENSITY; CONTRACEPTIVES, ORAL, SYNTHETIC; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; OSTEOPOROSIS;

EID: 20444447395     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2005.03.007     Document Type: Note

References (0)